Skip to main content
Caplight Logo









Keylika

Keylika

Private
Walnut Creek, CaliforniaHealthcare & Life Scienceshttps://keylika.com

Last Round

Seed

Sep 7, 2022

Total Funding Raised

$500,000

Company Overview

Keylika operates in Healthcare & Life Sciences and is based in Walnut Creek, California. Its latest recorded funding round was a Seed round in September 2022.

Keylika is a biopharmaceutical company that develops metal-based drugs using a platform synthesis technology for the treatment of iron deficiency anemia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Keylika Comparables

Compare Keylika with similar companies based on industry and business-model similarity.

Keylika comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fe3 Medical
81%
Fe3 Medical
75%
AFYX Therapeutics A/S
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Keylika Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 7, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Buddhadev P. Chaudhuri

CEO & Co-Founder

Founding Team

Frederik Ceyssens

CTO

Executive Team

For institutional investors. Book with your work email.

Keylika Investors

Notable investors and investment history

Keylika investors
InvestorRounds
GaingelsSeed
Y CombinatorSeed
FundamentSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2022

    $500K round led by Y Combinator

Book a demo to see all signals

For institutional investors. Book with your work email.

Keylika Filings

Explore SEC and related filing metadata, where available.

Keylika filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Keylika's valuation, stock price, and market status.

Is Keylika a public or private company?

Keylika is a private company.

What is the current stock price of Keylika?

Keylika is a private company, so its shares have no public market price. Caplight tracks Keylika's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Keylika worth (valuation)?

Valuation information for Keylika is not publicly available.

Can I buy Keylika stock?

Keylika shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Keylika's last funding round?

Keylika's most recent funding round was Seed on September 7, 2022.

Who are the main investors in Keylika?

Key investors in Keylika include Y Combinator.

Will Keylika IPO soon?

No public IPO plans have been announced for Keylika.

How can I track Keylika secondary market activity?

Caplight tracks bids, offers, and trades in Keylika's shares on secondary markets.

Firmographic Details

HeadquartersWalnut Creek, California
Employee Range2
Year Founded2022
Last FundingSep 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?